| 1 |
Cankařová N, Krchňák V. Regioselective Cyclic Iminium Formation of Ugi Advanced Intermediates: Rapid Access to 3,4-Dihydropyrazin-2(1H)-ones and Other Diverse Nitrogen-Containing Heterocycles. Molecules 2023;28:3062. [DOI: 10.3390/molecules28073062] [Reference Citation Analysis]
|
| 2 |
Gattu R, Ramesh SS, Nadigar S, D CG, Ramesh S. Conjugation as a Tool in Therapeutics: Role of Amino Acids/Peptides-Bioactive (Including Heterocycles) Hybrid Molecules in Treating Infectious Diseases. Antibiotics (Basel) 2023;12:532. [PMID: 36978399 DOI: 10.3390/antibiotics12030532] [Reference Citation Analysis]
|
| 3 |
Ding D, Xu S, da Silva-Júnior EF, Liu X, Zhan P. Medicinal chemistry insights into antiviral peptidomimetics. Drug Discov Today 2023;28:103468. [PMID: 36528280 DOI: 10.1016/j.drudis.2022.103468] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 4 |
Gomes PSFC, Forrester M, Pace M, Gomes DEB, Bernardi RC. May the force be with you: The role of hyper-mechanostability of the bone sialoprotein binding protein during early stages of Staphylococci infections. Front Chem 2023;11:1107427. [PMID: 36846849 DOI: 10.3389/fchem.2023.1107427] [Reference Citation Analysis]
|
| 5 |
Lamartina CW, Chartier CA, Lee S, Shah NH, Rovis T. Modular Synthesis of Unnatural Peptides via Rh(III)-Catalyzed Diastereoselective Three-Component Carboamidation Reaction. J Am Chem Soc 2023;145:1129-35. [PMID: 36576945 DOI: 10.1021/jacs.2c10793] [Reference Citation Analysis]
|
| 6 |
Zhang H, Liu C, Zhu D, Zhang Q, Li J. Medicinal Chemistry Strategies for the Development of Inhibitors Disrupting β-Catenin's Interactions with Its Nuclear Partners. J Med Chem 2023;66:1-31. [PMID: 36583662 DOI: 10.1021/acs.jmedchem.2c01016] [Reference Citation Analysis]
|
| 7 |
Shapira L, Lerner S, Assayag G, Vardi A, Haham D, Bar G, Kozokaro VF, Robicsek ME, Lerner I, Michaeli A. Discovery of novel spike/ACE2 inhibitory macrocycles using in silico reinforcement learning. Front Drug Discov 2022;2. [DOI: 10.3389/fddsv.2022.1085701] [Reference Citation Analysis]
|
| 8 |
Gomari MM, Abkhiz S, Pour TG, Lotfi E, Rostami N, Monfared FN, Ghobari B, Mosavi M, Alipour B, Dokholyan NV. Peptidomimetics in cancer targeting. Mol Med 2022;28:146. [PMID: 36476230 DOI: 10.1186/s10020-022-00577-3] [Reference Citation Analysis]
|
| 9 |
Callis TB, Garrett TR, Montgomery AP, Danon JJ, Kassiou M. Recent Scaffold Hopping Applications in Central Nervous System Drug Discovery. J Med Chem 2022. [PMID: 36206553 DOI: 10.1021/acs.jmedchem.2c00969] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 10 |
Monkovic JM, Gibson H, Sun JW, Montclare JK. Fluorinated Protein and Peptide Materials for Biomedical Applications. Pharmaceuticals 2022;15:1201. [DOI: 10.3390/ph15101201] [Reference Citation Analysis]
|
| 11 |
Gonzalez P, Sabater L, Mathieu E, Faller P, Hureau C. Why the Ala-His-His Peptide Is an Appropriate Scaffold to Remove and Redox Silence Copper Ions from the Alzheimer’s-Related Aβ Peptide. Biomolecules 2022;12:1327. [DOI: 10.3390/biom12101327] [Reference Citation Analysis]
|
| 12 |
Thakur A, Sharma A, Alajangi HK, Jaiswal PK, Lim YB, Singh G, Barnwal RP. In pursuit of next-generation therapeutics: Antimicrobial peptides against superbugs, their sources, mechanism of action, nanotechnology-based delivery, and clinical applications. Int J Biol Macromol 2022;218:135-56. [PMID: 35868409 DOI: 10.1016/j.ijbiomac.2022.07.103] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
